Cargando…
Prognostic model for multiple myeloma progression integrating gene expression and clinical features
BACKGROUND: Multiple myeloma (MM) is a hematological cancer caused by abnormal accumulation of monoclonal plasma cells in bone marrow. With the increase in treatment options, risk-adapted therapy is becoming more and more important. Survival analysis is commonly applied to study progression or other...
| Autores principales: | , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Oxford University Press
2019
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6936209/ https://www.ncbi.nlm.nih.gov/pubmed/31886876 http://dx.doi.org/10.1093/gigascience/giz153 |